BioMarin Pharmaceutical Inc.

US$56.03As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BMRNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (3.55%)
Div yield —
ROE (0.31%)
Biotechnology
Beta (5Y) 0.23
PE TTM —
TSR TTM 4.59%
Mkt cap US$10.85B
ROIC (2.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$62
10.92%
428.56%
Hold 8|1|3|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.02
1.00
0.95
1.00
17.30%
8.33%
5.76%
0.74%
Revenue$M
953.9
963.6
987.3
992.2
5.69%
7.93%
11.68%
10.19%
Peers (US$10.85B)
Cap (US$)
PE
11.43B
66.21x
10.11B
—
10.29B
76.81x
Capital
TTM
5Y
10Y
Leveragex
1.354
2.032
1.562
EBIT/Intx
5.728
0.103
0.087
Own earn%
34.74
132.21
119.96
Sh yield%
43.23
13.20
13.69
Owners
Insiders/Inst%
7.97
66.99
Short interest%
2.97
SBC / revenue%
4.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
3–10
$1 testx
—
Incr. ROIC%
5